Alpha-l-Antitrypsin is a plasma protease inhibitor that accounts for 90% of the total anti-protease activity in blood. Although synthesized mainly in the liver, its physiological function is to diffuse into the lung and protect this important organ from destruction by excessive neutrophil elastase. Genetic deficiency of alpha1-antitrypsin predisposes affected individuals to develop chronic obstructive pulmonary emphysema and there is no cure for this fatal condition at the present time. The deficient individuals have a general life expectancy of about 40-50 years, which can be shortened 10-20 years for cigarette smokers. The genetic deficiency is inherited as an autosomal co-dominant trait, and has a prevalence of about 1 in 3,000-4,000 Caucasians of Northern European ancestry. The protein in deficiency individuals has a lysine instead of a glytamate at residue 342 in the carboxyl region. Having cloned and analyzed the human alpha1-antitrypsin cDNA and its chromosomal gene, we demonstrated that the amino acid substitution is caused by a G to A transition at the corresponding position in the gene. The mutation information has permitted the development of analytical procedures for prenatal diagnosis and carrier detection of this genetic disorder. The full length cDNA was also introduced into retroviral vectors and used to transduce fibroblasts, hepatoma cells as well as primary mouse hepatocytes in culture. All virally transduced cells synthesized and secreted into culture media authentic human alpha1-antitrypsin which was fully capable of inactivating neutrophil elastase in vitro. More recently we have created transgenic mice on inbred lines that expressed high levels of human alpha1-antitrypsin in the liver, and used them as donors for hepatocyte transplantation into congenic recipients. We demonstrated that hepatocytes injected into the portal vein or the spleen of recipient mice migrated to the liver, embedded into the parenchyma, lived and continued to function as hepatocytes for the life of the recipients. In the current proposal we will attempt hepatic gene therapy by retroviral gene transduction followed by hepatocellular transplantation in laboratory animals. We will also attempt direct delivery of genes to the liver by forming DNA complexes with asialo-orosomucoid which is rapidly endocytosed into hepatocytes through the asialo- glycoprotein receptor. Finally, we will develop the adeno-associated virus as an alternative vector for in vitro as well as in vivo gene delivery to the liver and lung tissues in order to achieve gene therapy for alpha1-antitrypsin deficiency.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL040162-08
Application #
2219500
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1987-09-30
Project End
1996-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
8
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Guo, Z S; Wang, L H; Eisensmith, R C et al. (1996) Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther 3:802-10
Kay, M A; Graham, F; Leland, F et al. (1995) Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21:815-9
Kay, M A; Rothenberg, S; Landen, C N et al. (1993) In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262:117-9
Li, Q; Kay, M A; Finegold, M et al. (1993) Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 4:403-9
Kolodka, T M; Finegold, M; Kay, M A et al. (1993) Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo. Somat Cell Mol Genet 19:491-7
Kay, M A; Baley, P; Rothenberg, S et al. (1992) Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A 89:89-93
Ponder, K P; Dunbar, R P; Wilson, D R et al. (1991) Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum Gene Ther 2:41-52
Ponder, K P; Gupta, S; Leland, F et al. (1991) Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A 88:1217-21
Armentano, D; Thompson, A R; Darlington, G et al. (1990) Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. Proc Natl Acad Sci U S A 87:6141-5
Ledley, F D (1990) Clinical application of somatic gene therapy in inborn errors of metabolism. J Inherit Metab Dis 13:597-616

Showing the most recent 10 out of 11 publications